Warburg Pincus and Mubadala completed the acquisition of the pharma intelligence business of Informa for $2.6bn.

Private equity firms Warburg Pincus and Mubadala, completed the acquisition of the pharma intelligence business of Informa, a British publishing, business intelligence, and exhibitions group, for $2.6bn. “We are delighted that the acquisition is complete, and we can focus our efforts entirely on the next phase of growth. Working closely with Jay Nadler and the management team, we will build on the excellent work already undertaken and use our industry expertise and experience successfully scaling pharma, health tech and B2B information services businesses, to help the company achieve its growth potential," Adarsh Sarma, Warburg Pincus Co-Head of Europe.